Company Information

CIN
Status
Date of Incorporation
13 September 2007
State / ROC
Hyderabad / ROC Hyderabad
Last Balance Sheet
31 March 2022
Last Annual Meeting
30 September 2022
Paid Up Capital
40,287,050
Authorised Capital
200,000,000

Directors

Ravishanker Kovi
Ravishanker Kovi
Director/Designated Partner
about 2 years ago
Vineeth Madala
Vineeth Madala
Director/Designated Partner
over 2 years ago

Past Directors

Srilakshmi Madala
Srilakshmi Madala
Director
about 17 years ago
Madhavi Thirividhi
Madhavi Thirividhi
Director
about 17 years ago
Murali Krishna Madala
Murali Krishna Madala
Director
about 18 years ago

Patents

An Improved Process For Preparing 2 Chloromethyl 3, 4 Dimethoxy Pyridine Hydrochloride

ABSTRACT AN IMPROVED PROCESS FOR PREPARING 2-CHLOROMETHYL-3, 4-DIMETHOXY PYRIDINE HYDROCHLORIDE The present invention relates to an improved process for the preparation of Pantoprazole intermediate or its pharmaceutically acceptable salts. The present invention specifically relates to an improved process for the p...

A Novel Process For The Preparation Of Itraconazole And Intermediates Of Itraconazole

ABSTRACT The present invention relates to a novel process for the preparation of triazole antifungal agents or its pharmaceutically acceptable salts. The present invention particularly relates novel process for the preparation of Itraconazole or its pharmaceutically acceptable salts. The present invention also rela...

Green Process For Preparation Of Benzimidazole Derivatives

The present invention relates to a green process for the preparation of 5-Difluoromethoxy-2-mercapto-1H-benzimidazole of formula (I), (I). The process for preparation of the compound of formula (I) comprises O-alkylation of N-(4-hydroxyphenyl)acetamide, nitration of N-[4-(difluoromethoxy)phenyl]acetamide, reduct...

Process For The Preparation Of Dolutegravir Key Intermediate

Process for the preparation of Dolutegravir Key intermediate” An improved and new method for the preparation of 1-(2,2-dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid of the formula (IX), a key and core intermediate of Dolutegravir.

An Economical And Efficient Industrial Process For The Preparation Of Triazolone Intermediate

TITLE: ‘AN ECONOMICAL AND EFFICIENT INDUSTRIAL PROCESS FOR THE PREPARATION TRIAZOLONE INTERMEDIATE’’ ABSTRACT The present invention relates to an economical and efficient industrial process for the preparation of triazolone intermediate having the formula (I). The present invention further relates to a method ...

Charges

96 Crore
08 February 2019
Hdfc Bank Limited
22 Lak
11 August 2017
Edelweiss Retail Finance Limited
1 Crore
11 August 2017
Edelweiss Retail Finance Limited
1 Crore
03 April 2017
Axis Bank Limited
16 Crore
03 April 2017
Axis Bank Limited
24 Crore
23 April 2008
State Bank Of Hyderabad
8 Crore
02 July 2012
Staste Bank Of Hyderabad
17 Crore
13 May 2021
Hdfc Bank Limited
43 Crore
22 April 2021
Bajaj Finance Limited
10 Crore
28 February 2023
Others
0
28 February 2023
Others
0
12 July 2022
Others
0
28 February 2022
Others
0
13 May 2021
Hdfc Bank Limited
0
03 April 2017
Axis Bank Limited
0
22 April 2021
Others
0
02 July 2012
Others
0
11 August 2017
Others
0
11 August 2017
Others
0
03 April 2017
Axis Bank Limited
0
08 February 2019
Hdfc Bank Limited
0
23 April 2008
Others
0
28 February 2023
Others
0
28 February 2023
Others
0
12 July 2022
Others
0
28 February 2022
Others
0
13 May 2021
Hdfc Bank Limited
0
03 April 2017
Axis Bank Limited
0
22 April 2021
Others
0
02 July 2012
Others
0
11 August 2017
Others
0
11 August 2017
Others
0
03 April 2017
Axis Bank Limited
0
08 February 2019
Hdfc Bank Limited
0
23 April 2008
Others
0
28 February 2023
Others
0
28 February 2023
Others
0
12 July 2022
Others
0
28 February 2022
Others
0
13 May 2021
Hdfc Bank Limited
0
03 April 2017
Axis Bank Limited
0
22 April 2021
Others
0
02 July 2012
Others
0
11 August 2017
Others
0
11 August 2017
Others
0
03 April 2017
Axis Bank Limited
0
08 February 2019
Hdfc Bank Limited
0
23 April 2008
Others
0